PeopleBio Announces 2-for-1 Reverse Stock Split and Capital Reduction to Strengthen Financial Position
PeopleBio will hold an extraordinary general meeting on July 20, 2026 to approve a stock consolidation, articles amendment, and reduction of capital surplus to cover deficits.
The consolidation merges 2 shares of 500 won par value into 1 share of 1,000 won, reducing outstanding shares from 24,320,660 to 12,160,330.
The share price is expected to rise from 984 won to approximately 1,968 won, with no change in market capitalization.
The reduction of capital surplus is aimed at improving the company's financial structure.
[AI Summary]The reverse stock split reduces share count and increases per share price, which may enhance investor perception but does not alter fundamental value. The capital surplus reduction is an accounting adjustment to reflect past losses.
KOSDAQ Filing Information
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)